resiquimod has been researched along with AIDS, Simian in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, KJ; Kanuma, T; Moriishi, E; Okamura, T; Takahama, S; Terahara, K; Yamamoto, T; Yasutomi, Y | 1 |
| Elbim, C; Lizard, G | 1 |
1 review(s) available for resiquimod and AIDS, Simian
| Article | Year |
|---|---|
Flow cytometric investigation of neutrophil oxidative burst and apoptosis in physiological and pathological situations.
Topics: Adjuvants, Immunologic; Animals; Apoptosis; Flow Cytometry; Humans; Imidazoles; Interleukin-1 Receptor-Associated Kinases; Lipopolysaccharides; NADPH Oxidases; Neutrophils; Oligodeoxyribonucleotides; Reactive Oxygen Species; Respiratory Burst; Simian Acquired Immunodeficiency Syndrome; Toll-Like Receptors | 2009 |
1 other study(ies) available for resiquimod and AIDS, Simian
| Article | Year |
|---|---|
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques.
Topics: Animals; CD8-Positive T-Lymphocytes; Dinucleoside Phosphates; Imidazoles; Leukocytes, Mononuclear; Macaca fascicularis; Male; Membrane Proteins; Nucleotides, Cyclic; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocytes, Cytotoxic; Toll-Like Receptors; Viral Load; Virus Activation; Virus Latency | 2019 |